| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/01/2006 | DE102004057503A1 Diagnostic system for blood sugar measurement in human blood, comprises diagnostic module integrated with lancet system, magazine module for storing test stripes, connecting device for connecting the modules using dove tail guidance |
| 06/01/2006 | DE102004056980A1 Verfahren zur ortsspezifischen Synthese von Biopolymeren auf festen Trägern A method for site-specific synthesis of biopolymers on solid supports |
| 06/01/2006 | DE102004056655A1 Probenröhrchen zur Aufnahme von Körperflüssigkeiten, insbesondere Blut Sample tube to absorb body fluids, especially blood |
| 06/01/2006 | DE102004056516A1 Verfahren zur Befestigung flexibler, elektrochemischer Sensoren A method of securing flexible electrochemical sensors |
| 06/01/2006 | DE102004056092A1 Determining probability of death in patients, especially in intensive care, involves using a blood sample analyser to measure a range of standard values and a computer to calculate a numerical probability from the data |
| 06/01/2006 | DE102004054928A1 Test strip, useful for detecting analytes in liquids, comprises carrier layer with reagent(s) impregnated absorbing test layer, which with one thin material present on the side next to the test layer couples with the carrier layer |
| 06/01/2006 | DE102004031370A9 Vorrichtung und Verfahren zur Emulation einer Gegenelektrode in einem monolithisch integrierten elektrochemischen Analysesystem Apparatus and method for emulating a counter electrode in a monolithic integrated electrochemical analysis system |
| 06/01/2006 | DE102004006470B4 Absorptionsphotometrisches Verfahren zur quantitativen Stoffanalyse Absorption spectrometric method for the quantitative analysis of substances |
| 06/01/2006 | DE10150959B4 Verfahren zur quantitativen Bestimmung viraler Partikel mit cholesterinhaltiger Hülle A method for quantitative determination of viral particles with cholesterol-shell |
| 06/01/2006 | CA2630475A1 Mer diagnostic and therapeutic agents |
| 06/01/2006 | CA2589754A1 Yeast strain and screening method for identifying inhibitors of the expression of the hexose transporter genes by a positive phenotype |
| 06/01/2006 | CA2589561A1 Treatment of neurodegenerative diseases by the use of laptm4a |
| 06/01/2006 | CA2589487A1 Means and methods for detecting methylated dna |
| 06/01/2006 | CA2589471A1 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
| 06/01/2006 | CA2589459A1 Method of measuring cholesterol in remnant-like lipoproteins |
| 06/01/2006 | CA2589291A1 Method of detecting kidney dysfunction |
| 06/01/2006 | CA2589251A1 Diagnostic method for the forecasting of transplanted organ loosing |
| 06/01/2006 | CA2589195A1 Particle-based multiplex assay for identifying glycosylation |
| 06/01/2006 | CA2589173A1 Use of eph receptor inhibitors for the treatment of neurodegenerative diseases |
| 06/01/2006 | CA2589114A1 Sample transfer system |
| 06/01/2006 | CA2589009A1 Method for identifying and designing immunogenic peptides |
| 06/01/2006 | CA2588997A1 Sensing phage-triggered ion cascade (septic) |
| 06/01/2006 | CA2588992A1 Protein biochip for validating binding agents |
| 06/01/2006 | CA2588893A1 Immunologic assay for detection of autoantibodies to folate binding protein |
| 06/01/2006 | CA2588420A1 Device and method for detection of analytes |
| 06/01/2006 | CA2588126A1 Optical system for cell imaging |
| 06/01/2006 | CA2587889A1 Antigenic epitopes of interleukin-21, related antibodies and their use in medical field |
| 06/01/2006 | CA2502479A1 Laminin receptor binding molecule |
| 06/01/2006 | CA2488777A1 Laminin receptor binding molecule |
| 05/31/2006 | EP1662412A2 Pathological diagnosis support device, program, method, and system |
| 05/31/2006 | EP1662260A1 Method of analyzing protein and protein analysis reagent to be used therein |
| 05/31/2006 | EP1662259A1 Use of Eph receptor inhibitors for the treatment of neurodegenerative diseases |
| 05/31/2006 | EP1662258A1 A substrate free in vitro protein kinase assay |
| 05/31/2006 | EP1662257A1 Tool for measuring object to be measured, measuring device, and measuring method |
| 05/31/2006 | EP1662256A1 Tailored magnetic particles and method to produce same |
| 05/31/2006 | EP1662255A2 Homer interacting proteins |
| 05/31/2006 | EP1662007A1 Preventive or remedy for inflammatory bowel diseases containing anti-cd81 antibody as the active ingredient |
| 05/31/2006 | EP1661998A2 Antigenic polypeptides, antibodies binding thereto, nucleic acids encoding the antigens, and methods of use |
| 05/31/2006 | EP1661997A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/31/2006 | EP1661996A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/31/2006 | EP1661995A1 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 05/31/2006 | EP1661994A1 Therapeutic agent for NGF |
| 05/31/2006 | EP1661993A1 SLY1 inhibitors in organ, tissue and cell transplantation |
| 05/31/2006 | EP1661991A1 Hepatocellular cancer-associated gene |
| 05/31/2006 | EP1661990A1 Polypeptide specific to liver cancer, polynucleotide encoding the polypeptide and rna molecule inhibiting the expression of the polypeptide |
| 05/31/2006 | EP1661915A1 Preparation of antibodies against the human chitinase-like protein GL008 |
| 05/31/2006 | EP1661910A1 Peptides capable of binding to titanium, silver and silicone |
| 05/31/2006 | EP1661908A1 Reagent for amplifying amyloid fibrosis of amyloid beta-protein |
| 05/31/2006 | EP1661906A1 Method of preparing solution having composition of biological components |
| 05/31/2006 | EP1661625A1 Apparatus for retaining magnetic particles within a flow-through cell |
| 05/31/2006 | EP1661581A1 Remedy for cardiac failure comprising ask1 inhibitor as the active ingredient and method of screening the same |
| 05/31/2006 | EP1661514A2 Apparatus and method for diagnostic gas analysis |
| 05/31/2006 | EP1660970A2 Systems and methods for biopolymer engineering |
| 05/31/2006 | EP1660889A1 Diagnostic composition for diabetes type-2 and impaired glucose tolerance, and methods of use |
| 05/31/2006 | EP1660888A1 Method for detecting low levels of a fusion protein |
| 05/31/2006 | EP1660887A2 Method and diagnostic tests based on flow cytometric analysis of antigen-specific t lymphocytes |
| 05/31/2006 | EP1660886A1 Device for detecting biochemical activity containing gap junctions |
| 05/31/2006 | EP1660885A1 Reagent for producing a protein chip |
| 05/31/2006 | EP1660884A2 Crown ether derivatives |
| 05/31/2006 | EP1660880A1 Device and method for the quantitative evaluation of the polypeptides contained in a body fluid sample, and marker for the detection of pathological states |
| 05/31/2006 | EP1660871A2 Photoluminescent heterodiamondoids as biological labels |
| 05/31/2006 | EP1660869A1 Real-time on-line sensing and control of emulsions in formation fluids |
| 05/31/2006 | EP1660859A2 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 05/31/2006 | EP1660854A1 Pressure wave piezoelectric sensor |
| 05/31/2006 | EP1660686A2 Hpv cd8+ t-cell epitopes |
| 05/31/2006 | EP1660684A2 Pathogenic gene for coronary artery disease |
| 05/31/2006 | EP1660683A2 Methods and compositions for detecting colon cancers |
| 05/31/2006 | EP1660674A2 Expression profiling using microarrays |
| 05/31/2006 | EP1660671A2 Methods for screening and identifying compounds |
| 05/31/2006 | EP1660660A2 Polypeptides of streptococcus pyogenes |
| 05/31/2006 | EP1660638A2 Lipoparticles comprising proteins, methods of making, and using the same |
| 05/31/2006 | EP1660635A2 Methods and compositions comprising fatp5 for use in the diagnosis and treatment of metabolic disorders |
| 05/31/2006 | EP1660634A2 P16 mediated regulation of nmda receptors |
| 05/31/2006 | EP1660590A2 Cationic dye compound for detecting nucleic acid double strand, and detection method and apparatus using same |
| 05/31/2006 | EP1660568A1 Hydrophobic object comprising a grid of hydrophilic regions, production of said object, and use of the same |
| 05/31/2006 | EP1660535A2 Techniques and compositions for the diagnosis and treatment of cancer (muc1) |
| 05/31/2006 | EP1660524A2 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases |
| 05/31/2006 | EP1660518A2 Complexes of gpcr142 and relaxin3 or insl5, and their production and use |
| 05/31/2006 | EP1660502A2 MODULATION OF ß-CATENIN/TCF ACTIVATED TRANSCRIPTION |
| 05/31/2006 | EP1660128A2 Anti-fcrn antibodies for treatment of auto/allo immune conditions |
| 05/31/2006 | EP1660127A1 Antibodies to c-met |
| 05/31/2006 | EP1660114A1 Methods and compositions for treating disorders of the extracellular matrix |
| 05/31/2006 | EP1660072A2 Means and methods for treating a disease which is associated with an excess transport of hyaluronan across a lipid bilayer |
| 05/31/2006 | EP1660010A2 Compositions and methods for restoring sensitivity to treatment with her2 antagonists |
| 05/31/2006 | EP1659933A2 Method of constructing a biosensor |
| 05/31/2006 | EP1659881A2 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 05/31/2006 | EP1623207B1 Method for electrochemical detection and control of inorganic scale |
| 05/31/2006 | EP1604032A4 Method for detecting prognosis of cancer |
| 05/31/2006 | EP1576012A4 Monoclonal antibody against asialo alpha 1-acid glycoprotein, immunochromatographic strip comprising the monoclonal antibody, and method for diagnosing liver diseases using the immunochromatographic strip |
| 05/31/2006 | EP1554580A4 Inflammatory bowel disease and irritable bowel syndrome ibd-first chek diagnostic panel |
| 05/31/2006 | EP1549240A4 Whole blood sampling device |
| 05/31/2006 | EP1537423B1 Method for the local detection of inflammation and allergy mediators |
| 05/31/2006 | EP1534739A4 Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathways |
| 05/31/2006 | EP1499642A4 Dna dependent protein kinase catalytic subunit phosphorylation sites and antibodies thereto |
| 05/31/2006 | EP1478775A4 A rapid and sensitive proximity-based assay for the detection and quantification of dna binding proteins |
| 05/31/2006 | EP1470229B1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state |
| 05/31/2006 | EP1470133A4 Electrochemical saccharide sensor |
| 05/31/2006 | EP1410001A4 Multilayer analytical element and method for determination of analytes in fluids containing interfering substances |
| 05/31/2006 | EP1409743B1 Method and support for biological analysis using oligonucleotides comprising a marker capable of enzymatic activation |
| 05/31/2006 | EP1392847B1 A high throughput assay for identification of gene expression modifiers |